المؤلفون: Maria Grammoustianou, Foteinos-Ioannis Dimitrakopoulos, Angelos Koutras

المصدر: Cancers, Vol 16, Iss 10, p 1801 (2024)

مصطلحات موضوعية: antibody–drug conjugates, ADCs, hormone receptor-positive breast cancer, HER2-low breast cancer, HER2-negative breast cancer, endocrine resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/16/10/1801Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/1710fc3ff1d54b4e94fb5c5ab4793ad8Test

المؤلفون: Juan Jin, Bin Li, Jianing Cao, Ting Li, Jian Zhang, Jun Cao, Mingchuan Zhao, Leiping Wang, Biyun Wang, Zhonghua Tao, Xichun Hu

المصدر: Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-16 (2023)

مصطلحات موضوعية: HER2-low breast cancer, Antibody–drug conjugates, HER2 expression, HER2 dynamics, Metastatic breast cancer, Heterogeneity, Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1479-5876Test

الوصول الحر: https://doaj.org/article/feeb8b6d8ae14d6982b8b819747c5496Test

المؤلفون: Yingying Zhao, Xinru Chen, Yaohui Wang, Xueqing Zhang, Jingsong Lu, Wenjin Yin

المصدر: Journal of Clinical Medicine, Vol 13, Iss 7, p 1850 (2024)

مصطلحات موضوعية: HER2-low breast cancer, prognosis, Neo-Bioscore, HER2-zero, HER2-positive, Medicine

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2077-0383/13/7/1850Test; https://doaj.org/toc/2077-0383Test

الوصول الحر: https://doaj.org/article/23adda280b1a45209d259c8aadbad02bTest

المؤلفون: Wang J, Liao D, Zhang X, Miao C, Chen K

المصدر: Breast Cancer: Targets and Therapy, Vol Volume 15, Pp 281-294 (2023)

مصطلحات موضوعية: her2-low breast cancer, monoclonal antibodies, antibody–drug conjugates, trastuzumab deruxtecan, immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/can-patients-withTest-her2-low-breast-cancer-benefit-from-anti-her2-therap-peer-reviewed-fulltext-article-BCTT; https://doaj.org/toc/1179-1314Test

الوصول الحر: https://doaj.org/article/90ba8d3a47cd4887822fbc8005841dc8Test

المؤلفون: Shuling Zhou, Ting Liu, Xiaying Kuang, Tiantian Zhen, Huijuan Shi, Ying Lin, Nan Shao

المصدر: Breast, Vol 67, Iss , Pp 1-7 (2023)

مصطلحات موضوعية: HER2-low breast cancer, Neoadjuvant chemotherapy, Pathological complete response, Survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S0960977622001989Test; https://doaj.org/toc/1532-3080Test

الوصول الحر: https://doaj.org/article/3106b4fc4b3a4ab7addaf132f290d2e1Test

المؤلفون: Lang Y, Wu B, Liu X

المصدر: Breast Cancer: Targets and Therapy, Vol Volume 14, Pp 453-463 (2022)

مصطلحات موضوعية: cost-effectiveness, her2-low breast cancer, trastuzumab deruxtecan, partitioned survival approach, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/economic-evaluation-of-trastuzumab-deruxtecan-in-previously-treated-he-peer-reviewed-fulltext-article-BCTTTest; https://doaj.org/toc/1179-1314Test

الوصول الحر: https://doaj.org/article/17ca4d596e3e400ea9344aa1103d55f3Test

المؤلفون: Arya Mariam Roy, Changchuan Jiang, Stuthi Perimbeti, Lei Deng, Charles L. Shapiro, Shipra Gandhi

المصدر: Cancers, Vol 15, Iss 17, p 4264 (2023)

مصطلحات موضوعية: HER2-low breast cancer, HER2-zero breast cancer, Oncotype Dx, hormone-positive breast cancer, hormone-negative breast cancer, anti-HER2 agents, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/15/17/4264Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/7037c61974ac4e23ad3c712a504b0097Test

المؤلفون: Ryan Shea Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, Abner Herbert Lim, Seri Park, Yeon Hee Park, Ching-Hung Lin, Yen-Shen Lu, Makiko Ono, Takayuki Ueno, Yoichi Naito, Tatsuya Onishi, Geok-Hoon Lim, Su-Ming Tan, Han-Byoel Lee, Han Suk Ryu, Wonshik Han, Veronique Kiak Mien Tan, Fuh-Yong Wong, Seock-Ah Im, Puay Hoon Tan, Jason Yongsheng Chan, Yoon-Sim Yap

المصدر: BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)

مصطلحات موضوعية: HER2-low breast cancer, ERBB2 neutral, Prognosis, TCGA, METABRIC, Medicine

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1741-7015Test

الوصول الحر: https://doaj.org/article/5bcb88b9c97b4e58a2441f664f3d4ca5Test

المؤلفون: von Arx C., De Placido P., Caltavituro A., Di Rienzo R., Buonaiuto R., De Laurentiis M., Arpino G., Puglisi F., Giuliano M., Del Mastro L.

المساهمون: von Arx, C., De Placido, P., Caltavituro, A., Di Rienzo, R., Buonaiuto, R., De Laurentiis, M., Arpino, G., Puglisi, F., Giuliano, M., Del Mastro, L.

مصطلحات موضوعية: ADC, Colon-rectal cancer, Gastric cancer, HER2-low breast cancer, Non-small-cell lung cancer, Trastuzumab

العلاقة: volume:113; journal:CANCER TREATMENT REVIEWS; https://hdl.handle.net/11390/1239943Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85145329831

الإتاحة: https://doi.org/10.1016/j.ctrv.2022.102500Test
https://hdl.handle.net/11390/1239943Test

المؤلفون: Tan, Ryan Shea Ying Cong, Ong, Whee Sze, Lee, Kyung-Hun, Lim, Abner Herbert, Park, Seri, Park, Yeon Hee, Lin, Ching-Hung, Lu, Yen-Shen, Ono, Makiko, Ueno, Takayuki, Naito, Yoichi, Onishi, Tatsuya, Lim, Geok-Hoon, Tan, Su-Ming, Lee, Han-Byoel, Ryu, Han Suk, Han, Wonshik, Tan, Veronique Kiak Mien, Wong, Fuh-Yong, Im, Seock-Ah, Tan, Puay Hoon, Chan, Jason Yongsheng, Yap, Yoon-Sim

المساهمون: 임석아, 한원식, Han, Wonshik, Im, Seock-Ah

مصطلحات موضوعية: CLINICAL ONCOLOGY/COLLEGE, AMERICAN SOCIETY, PROGNOSTIC-FACTOR, IMMUNOHISTOCHEMISTRY, RECOMMENDATIONS, IMPACT, PLUS, HER2-low breast cancer, ERBB2 neutral, Prognosis, TCGA, METABRIC

العلاقة: BMC Medicine, Vol.20 No.1, p. 105; 157929; https://hdl.handle.net/10371/179228Test; 000769987500001; 2-s2.0-85126377116

الإتاحة: https://doi.org/10.1186/s12916-022-02284-6Test
https://hdl.handle.net/10371/179228Test